PL3342856T3 - Preparaty jednojądrzastych komórek krwi obwodowej poddane niedotlenieniu - Google Patents

Preparaty jednojądrzastych komórek krwi obwodowej poddane niedotlenieniu

Info

Publication number
PL3342856T3
PL3342856T3 PL17211074.4T PL17211074T PL3342856T3 PL 3342856 T3 PL3342856 T3 PL 3342856T3 PL 17211074 T PL17211074 T PL 17211074T PL 3342856 T3 PL3342856 T3 PL 3342856T3
Authority
PL
Poland
Prior art keywords
hypoxia
peripheral blood
mononucleate cells
formulations subjected
cells formulations
Prior art date
Application number
PL17211074.4T
Other languages
English (en)
Inventor
Massimo Costa
Laura Olga Elena REHAK
Graziano PANFILI
Original Assignee
Quantix Swiss Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quantix Swiss Sa filed Critical Quantix Swiss Sa
Publication of PL3342856T3 publication Critical patent/PL3342856T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
    • C12N2500/62—DMSO

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL17211074.4T 2016-12-29 2017-12-29 Preparaty jednojądrzastych komórek krwi obwodowej poddane niedotlenieniu PL3342856T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000132406A IT201600132406A1 (it) 2016-12-29 2016-12-29 Preparato autologo di cellule mononucleate da sangue periferico sottoposte a precondizionamento in ipossia

Publications (1)

Publication Number Publication Date
PL3342856T3 true PL3342856T3 (pl) 2022-10-10

Family

ID=58737713

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17211074.4T PL3342856T3 (pl) 2016-12-29 2017-12-29 Preparaty jednojądrzastych komórek krwi obwodowej poddane niedotlenieniu

Country Status (6)

Country Link
EP (1) EP3342856B1 (pl)
ES (1) ES2923925T3 (pl)
IT (1) IT201600132406A1 (pl)
LT (1) LT3342856T (pl)
PL (1) PL3342856T3 (pl)
PT (1) PT3342856T (pl)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130121979A1 (en) * 2003-12-29 2013-05-16 Allan Mishra Method of treating cancer using platelet compositions
WO2014126931A1 (en) * 2013-02-15 2014-08-21 Victor Steven Stable platelet- rich-plasma compositions and methods of use

Also Published As

Publication number Publication date
PT3342856T (pt) 2022-08-09
LT3342856T (lt) 2022-08-10
EP3342856B1 (en) 2022-05-04
IT201600132406A1 (it) 2018-06-29
ES2923925T3 (es) 2022-10-03
EP3342856A1 (en) 2018-07-04

Similar Documents

Publication Publication Date Title
IL291163A (en) Clinical formulations
IL259211A (en) Oral care tool
PT3429644T (pt) Composição compatível com a pele
ZA201905379B (en) 1-amino-1-cyclopropanecaboxylic acid formulations
GB201617225D0 (en) Thickened skin care product
PL3288640T3 (pl) Kompozycja suchego szamponu
GB201408079D0 (en) Skin care composition
EP3349764A4 (en) SKIN CARE COMPOSITIONS
GB2558498B (en) Novel levothyroxine formulations for oral use
EP3295928A4 (en) External preparation for skin
GB201522223D0 (en) Therapeutic T cells
IL240032A0 (en) Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for their preparation and use
GB201414330D0 (en) Improvements to analysing physiological electrograms
ZA201504604B (en) Skin care composition
ZA201803987B (en) Topical skin care compositions comprising myrsine africana extracts
SG11201708597VA (en) Oral care composition
GB201514607D0 (en) Improvements relating to disinfectant solutions
PL3342856T3 (pl) Preparaty jednojądrzastych komórek krwi obwodowej poddane niedotlenieniu
GB201805338D0 (en) Cosmetic formulations
ZA201807951B (en) Skin care composition
HUP1600296A2 (en) Fungicide composition for female vaginal care
GB201620086D0 (en) Improvements relating to auction mechanisms
GB201621874D0 (en) Therapeutic Cells
GB201709974D0 (en) Stable electrolyte formulations
GB201519365D0 (en) Improvements relating to human body measurement